Free Access
| Issue |
Biologie Aujourd’hui
Volume 217, Number 3-4, 2023
|
|
|---|---|---|
| Page(s) | 151 - 154 | |
| DOI | https://doi.org/10.1051/jbio/2023023 | |
| Published online | 29 novembre 2023 | |
- Alnefeesi, Y., Chen-Li, D., Krane, E., Jawad, M.Y., Rodrigues, N.B., Ceban, F., Di Vincenzo, J.D., Meshkat, S., Ho, R.C.M., Gill, H., Teopiz, K.M., Cao, B., Lee, Y., McIntyre, R.S., Rosenblat, J.D. (2022). Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review and meta-analysis. J Psychiatr Res, 151, 693-709. [CrossRef] [PubMed] [Google Scholar]
- Bahji, A., Vazquez, G.H., Zarate, C.A. Jr. (2021). Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis. J Affect Disord, 278, 542-555. [CrossRef] [PubMed] [Google Scholar]
- Ballard, E.D., Zarate, C.A. Jr. (2020). The role of dissociation in ketamine’s antidepressant effects. Nat Commun, 11, 6431. [CrossRef] [PubMed] [Google Scholar]
- Berman, R.M., Cappiello, A., Anand, A., Oren, D.A., Heninger, G.R., Charney, D.S., Krystal, J.H. (2000). Antidepressant effects of ketamine in depressed patients. Biol Psychiatry, 47, 351-354. [CrossRef] [PubMed] [Google Scholar]
- Bottemanne, H., Morlaàs, O., Schmidt, L., Fossati, P. (2020). Coronavirus: Predictive brain and terror management. Encephale, 46(3S), S107-S113. [CrossRef] [PubMed] [Google Scholar]
- Bottemanne, H., Morlaas, O., Claret, A., Sharot, T., Fossati, P., Schmidt, L. (2022). Evaluation of early ketamine effects on belief-updating biases in patients with treatment-resistant depression. JAMA Psychiatry, 79, 1124-1132. [CrossRef] [PubMed] [Google Scholar]
- Fond, G., Loundou, A., Rabu, C., MacGregor, A., Lançon, C., Brittner, M., Micoulaud-Franchi, J.A., Richieri, R., Courtet, P., Abbar, M., Roger, M., Leboyer, M., Boyer, L. (2014). Ketamine administration in depressive disorders: A systematic review and meta-analysis. Psychopharmacology (Berl), 231, 3663-3676. [CrossRef] [PubMed] [Google Scholar]
- McGirr, A., Berlim, M.T., Bond, D.J., Fleck, M.P., Yatham, L.N., Lam, R.W. (2015). A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med, 45, 693-704. [CrossRef] [PubMed] [Google Scholar]
- McIntyre, R.S., Carvalho, I.P., Lui, L.M.W., Majeed, A., Masand, P.S., Gill, H., Rodrigues, N.B., Lipsitz, O., Coles, A.C., Lee, Y., Tamura, J.K., Iacobucci, M., Phan, L., Nasri, F., Singhal, N., Wong, E.R., Subramaniapillai, M., Mansur, R., Ho, R., Lam, R.W., Rosenblat, J.D. (2020). The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord, 276, 576-584. [CrossRef] [PubMed] [Google Scholar]
- McIntyre, R.S., Rosenblat, J.D., Nemeroff, C.B., Sanacora, G., Murrough, J.W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., Iosifescu, D.V., Lopez Jaramillo, C., Kasper, S., Kratiuk, K., Lee, J.G., Lee, Y., Lui, L.M.W., Mansur, R.B., Papakostas, G.I., Subramaniapillai, M., Thase, M., Vieta, E., Young, A.H., Zarate, C.A. Jr, Stahl, S. (2021). Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry, 178, 383-399. [CrossRef] [PubMed] [Google Scholar]
- Menon, V., Varadharajan, N., Faheem, A., Andrade, C (2023). Ketamine vs. electroconvulsive therapy for major depressive episode: A systematic review and meta-analysis. JAMA Psychiatry, 12, e230562. [Google Scholar]
- Niciu, M.J., Shovestul, B.J., Jaso, B.A., Farmer, C., Luckenbaugh, D.A., Brutsche, N.E., Park, L.T., Ballard, E.D., Zarate, C.A. Jr. (2018). Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression. J Affect Disord, 232, 310-315. [CrossRef] [PubMed] [Google Scholar]
- Rhee, T.G., Shim, S.R., Forester, B.P., Nierenberg, A.A., McIntyre, R.S., Papakostas, G.I., Krystal, J.H., Sanacora, G., Wilkinson, S.T. (2022). Efficacy and safety of ketamine vs. electroconvulsive therapy among patients with major depressive episode: A systematic review and meta-analysis. JAMA Psychiatry, 79, 1162-1172. [CrossRef] [PubMed] [Google Scholar]
- Romeo, B., Choucha, W., Fossati, P., Rotge, J.Y. (2015). Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression. Psychiatry Res, 230, 682-688. [CrossRef] [PubMed] [Google Scholar]
- Zarate, C.A. Jr., Singh, J.B., Carlson, P.J., Brutsche, N.E., Ameli, R., Luckenbaugh, D.A., Charney, D.S., Manji, H.K. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry, 63, 856-864. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.